Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. II. Economic evaluation

Journal of Rheumatology

Volumn 23, Issue 7, 1996, Pages 1246-1254

  Goossens, Marielle E J B ^a   Rutten van Mölken, Maureen P M H ^a   Leidl, Reiner M ^a   Bos, Stefan G P M ^a   Vlaeyen, Johan W S ^a   Teeken Gruben, Nicole J G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cognitive Behavioral; Costs; Fibromyalgia Economic Evaulation; Treatment Utilities Qaly

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EDUCATION PROGRAM; FEMALE; FIBROMYALGIA; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PHYSIOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; DIRECT SERVICE COSTS; ECONOMICS; EVALUATION STUDIES; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION; PSYCHOTHERAPY, GROUP; QUALITY-ADJUSTED LIFE YEARS; SENSITIVITY AND SPECIFICITY;

EID: 0029683643     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wolfe F: Fibromyalgia: The clinical syndrome. Rheum Dis Clin North Am 7 990/3:681-97.
2. Cathey BSN, Wolfe F, Kleinheksel SM, Hawley DJ: Socioeconomic impact of fibrositis. A study of 81 patients with primary fibrositis (abstr). AmJMed /986,-81:S3A.
3. Hawley DJ, Wolfe F, Cathey MA: Pain, functional disability and psychological status: A 12 month study of severity in fibromyalgia. JRheumatol ;988;15:1551-6.
4. Wolfe F, Smythe HA, Yunus MB, et al: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 7990;33:160-72.
5. McCain GA, Cameron R, Kennedy C: The problem of longterm disability payments and litigation in primary fibromyalgia: The Canadian perspective. J Rheumatol /989;(suppl 19)16:174-6.
6. de Girolamo G: Epidemiology and social costs of low back pain and fibromyalgia. Clin J Pain 799;,-(suppl 1)7:S1-S7.
7. Lightfoot RW, Luft BJ, Rahn DW, et al: Empiric parenteral antibiotic treatment of patients with fibromyalgia and fatigue and a positive sérologie result for Lyme disease. A cost-effectiveness analysis. Ann Intern Med /99J;119:503-9.
8. Koopmanschap MA, Rutten FFH: Indirect costs in economic studies: Confronting the confusion. Pharmacoeconomics 1993;4:446~54.
9. Bennett K, Torrance GR, Tugwell P: Methodologie challenges in the development of utility measures of Health-related Quality of Life in Rheumatoid Arthritis. Control Clin Trials 7997/(suppl)12:118-28.
10. Bakker CH, Rutten-van Mölken MPMH, van Doorslaer EKA, Bennet K, van der Linden S: Health related utility assessment by rating scale and standard gamble in patients with ankylosing spondylitis or fibromyalgia. Patient Education and Counseling 1993:20:145-52.
11. Torrance GW, Feeny D: Utilities and Quality-Adjusted Life Years. Int J Technol Assessment 7989/5:559-75.
12. Drummond MF, Stoddard GC, Torrance GW: Methods for the Evaluation of Health Care Programmes. Oxford: Oxford University Press, 1987.
13. Rutten-van Mölken MPMH, van Doorslaer EKA, van Vliet RCJA: Statistical analysis of cost outcomes in a randomized controlled clinical trial. Health Econ 7994/3:333-45.
14. Vlaeyen JWS, Teeken-Gruben NJC, Goossens MEJB, et al: Cognitive-educational treatment of fibromyalgia: A randomized clinical trial. I. Clinical effects. J Rheumatol 7996/23:1237-45.
15. Read JL, Quinn RJ, Berwick DM, et al: Preferences for health outcomes: Comparisons of assessment methods. Med Decis Making 1984:4:315-29.
16. Bleichrodt H: Testing the validity of expected utility theory in health state valuation: Some experimental results. Institute for Medical Technology Assessment paper no. 93.23. Rotterdam: Erasmus University of Rotterdam, 1993.
17. Rutten-van Mölken MPMH, Bakker CH, van Doorslaer EKA, et al: Methodological issues of patient utility measurement: Experience from two clinical trials. Med Care 7995/33:922-37.
18. Bakker CH, Rutten-van Mölken MPMH, van Doorslaer EKA, et al: Feasibility of utility assessment by rating scale and standard gamble in patients with ankylosing spondylitis or fibromyalgia. J Rheumatol 7994/21:269-74.
19. Bakker CH, Rutten-van Mölken MPMH, Kidding A, et al: Patient utilities in ankylosing spondylitis and the association with other outcome measures. J Rheumatol 7994/21:1298-304.
20. Mulley AG: Assessing patients' utilities. Can the ends justify the means? Med Care 7989/27:8269-81.